Portfolio

The next generation of life sciences innovation.

Leveraging a repeatable model of company builds and syndicated investments, Monograph backs life sciences teams positioned for long-term, risk-adjusted value creation.

Portfolio

The next generation of life sciences innovation.

Leveraging a repeatable model of company builds and syndicated investments, Monograph backs life sciences teams positioned for long-term, risk-adjusted value creation.

Portfolio

The next generation of life sciences innovation.

Leveraging a repeatable model of company builds and syndicated investments, Monograph backs life sciences teams positioned for long-term, risk-adjusted value creation.

Portfolio

The next generation of life sciences innovation.

Leveraging a repeatable model of company builds and syndicated investments, Monograph backs life sciences teams positioned for long-term, risk-adjusted value creation.

Portfolio

The next generation of life sciences innovation.

Leveraging a repeatable model of company builds and syndicated investments, Monograph backs life sciences teams positioned for long-term, risk-adjusted value creation.

All

All

Current

Current

Exited

Exited

Monograph Build

Monograph Build

Current

Current

Current

Current

Current

Current

Current

Current

Exited

Exited

Current

Current

Exited

Exited

Current

Current

Current

Current

Current

Current

Exited

Exited

Current

Current

Current

Current

Current

Current

Current

Current

Exited

Exited

© 2026 Monograph Capital. All rights reserved.

Monograph Capital Advisors (UK) LLP (FRN: 952340) is an Appointed Representative of Odin Capital Management Ltd (FRN: 478321), which is authorised and regulated by the Financial Conduct Authority.

© 2026 Monograph Capital. All rights reserved.

Monograph Capital Advisors (UK) LLP (FRN: 952340) is an Appointed Representative of Odin Capital Management Ltd (FRN: 478321), which is authorised and regulated by the Financial Conduct Authority.

© 2026 Monograph Capital. All rights reserved.

Monograph Capital Advisors (UK) LLP (FRN: 952340) is an Appointed Representative of Odin Capital Management Ltd (FRN: 478321), which is authorised and regulated by the Financial Conduct Authority.

© 2026 Monograph Capital. All rights reserved.

Monograph Capital Advisors (UK) LLP (FRN: 952340) is an Appointed Representative of Odin Capital Management Ltd (FRN: 478321), which is authorised and regulated by the Financial Conduct Authority.

© 2026 Monograph Capital. All rights reserved.

Monograph Capital Advisors (UK) LLP (FRN: 952340) is an Appointed Representative of Odin Capital Management Ltd (FRN: 478321), which is authorised and regulated by the Financial Conduct Authority.